omics news - the latest biotech news from Labiotech.eu

MOSAIC spatial atlas of cancer cells to be created

Jim Cornall — Fri, 09 Jun 2023 09:30:00 +0000

Owkin, NanoString Technologies and cancer research institutions University of Pittsburgh, Gustave Roussy, Lausanne University Hospital, Uniklinikum Erlangen/Friedrich-Alexander- Universität Erlangen-Nürnberg, and Charité – Universitätsmedizin Berlin are launching MOSAIC (Multi Omic Spatial Atlas In Cancer) at the American Society of Clinical Oncology’s annual meeting. MOSAIC is a $50 million project to revolutionize cancer research through the use […]

The post MOSAIC spatial atlas of cancer cells to be created appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

biomodal launches new multiomics sequencing technology

Jim Cornall — Fri, 14 Apr 2023 10:08:56 +0000

biomodal, formerly known as Cambridge Epigenetix, has launched its new duet multiomics solution, which it says reveals the combinatorial power of genetic and epigenetic information from a single low volume sample. The duet multiomics solution is the world’s first single-base-resolution sequencing technology that enables the simultaneous phased reading of genetic and epigenetic information in a […]

The post biomodal launches new multiomics sequencing technology appeared first on Labiotech.eu.

Via Scientific launches with multi-omics analytics platform

Jim Cornall — Fri, 03 Feb 2023 07:58:50 +0000

Via Scientific, Inc., a new U.S.-based technology and AI company, has launched Foundry, a multi-omics accelerator platform focused on significantly shortening the path to scientific breakthroughs. The Foundry platform was originally developed at UMass Chan Medical School. Via Scientific has exclusive commercial rights to the platform. Founders of the company are Melissa J. Moore, chief […]

The post Via Scientific launches with multi-omics analytics platform appeared first on Labiotech.eu.

JPND launches €16.5M call for research on OMICS data for neurodegenerative diseases

Jim Cornall — Thu, 12 Jan 2023 21:12:54 +0000

The EU Joint Programme – Neurodegenerative Disease Research (JPND) initiative has issued a call for multinational research on large scale analysis of OMICS data for drug-target finding in neurodegenerative diseases. Neurodegenerative diseases are debilitating and largely untreatable conditions that are strongly linked with age. Worldwide, there are estimated to be 50 million people with Alzheimer’s […]

The post JPND launches €16.5M call for research on OMICS data for neurodegenerative diseases appeared first on Labiotech.eu.

BioAge partners with Age Labs to study healthy life length

Jim Cornall — Wed, 24 Aug 2022 08:43:45 +0000

BioAge Labs, Inc., a biotech company developing therapeutics that target the molecular causes of aging to extend healthy human lifespan, has partnered with Age Labs AS, a diagnostic company that develops tests for the early detection of age-related diseases. Under the terms of the agreement, BioAge will perform multi-omics analyses on samples and health records […]

The post BioAge partners with Age Labs to study healthy life length appeared first on Labiotech.eu.

Development of cancer therapeutics accelerated by end-to-end single-cell multi-omics services

Liza Laws — Wed, 13 Jul 2022 11:31:49 +0000

Solid tumor assays have been launched by Mission Bio Inc., through its Pharma Assay Development (PAD) services. The availability of this new service offering from Mission Bio, a high-throughput single-cell DNA and multi-omics analysis company, will help accelerate the development of cancer therapeutics. It will do so by reducing the time and cost associated with […]

The post Development of cancer therapeutics accelerated by end-to-end single-cell multi-omics services appeared first on Labiotech.eu.

World’s first research project for an early detection, multi-cancer screening test launched in Singapore

Liza Laws — Fri, 08 Jul 2022 08:28:37 +0000

A project for the discovery and validation of new combinations of biomarkers that can detect multi-cancer early has been launched in Singapore. Biotechnology company, MiRXES Ptr Ltd, announced this week the signing of a memorandum of understanding signaling the launch of Project CADENCE (Cancer Detected Early caN be CurEd). It is the world’s first large-scale […]

The post World’s first research project for an early detection, multi-cancer screening test launched in Singapore appeared first on Labiotech.eu.